The aortic valve separates the left ventricle from the aorta. In normal hearts, it is pliable, opens widely, and presents minimal resistance to flow. The normal aortic valve is a trileaflet structure that is composed of three equal‐sized bowl‐shaped tissues that are referred to as cusps (left coronary cusp, right coronary cusp, and noncoronary cusp). The aortic valve serves an essential hemodynamic function in isolating the left ventricle from the arterial circulation and can fail in two ways. The valve can fail to open properly during systole, which thus inhibits ejection of blood from the left ventricle (aortic stenosis). Alternatively, the valve can fail by becoming incompetent, thus enabling back flow into the ventricle during diastole (aortic regurgitation) [1].
The hemodynamic changes associated with aortic regurgitation (AR) differ depending on the time–course of the valve dysfunction. If AR develops rapidly (i.e., acute or subacute AR), the left ventricle (LV) is unable to handle the pressure and volume overload, causing a rapid increase in LV pressures during diastole, markedly elevated pressures at end diastole, and premature closure of the mitral valve. Systemic diastolic pressures may be low, but generally there is a minimal increase in pulse pressure; in very severe cases of acute AR, cardiac output may fall, leading to hypotension. LV function can be further impaired by decreased coronary blood flow resulting from the combination of decreased aortic diastolic pressure and elevated LV diastolic pressures.
In chronic AR, stroke volume increases to maintain effective forward flow. This causes dilation of the LV, leading in some patients to the development of a massively dilated LV termed cor bovinum (the largest left ventricles are seen in patients with chronic AR). The body’s adaptation to chronic AR results, at least in part, in the classic physical examination findings of a widened pulse pressure and low aortic diastolic pressure. If and when the regurgitant flow overwhelms the adaptive mechanisms, this leads to uncompensated chronic AR with signs and symptoms of heart failure.
Before the development of aortic valve replacement, severe AR had an ominous prognosis. The availability of surgical treatment has greatly reduced the mortality of this disease (currently there are few percutaneous options available for AR, but several transcatheter valves that could be used to treat AR are in the development stage). The important question now in treating patients with this disease is the timing of aortic valve replacement. An understanding of the hemodynamic changes associated with chronic AR can help in determining cardiac adaptation to the regurgitant flow, and also help determine the severity of AR in patients with moderate AR by angiography or echo but decreased ejection fraction.